NSE
Krishna Institute of Medical Sciences LimitedKIMS
Krishna Institute of Medical Sciences Limited (KIMS) is a healthcare provider in India, known for its medical education and research facilities.
| Key products | Medical education, healthcare services |
|---|---|
| Geography | India |
| Competitors | Manipal Education & Healthcare, Apollo Hospitals Enterprises |
AI-generated overview — verify before relying on it.
Net institutional flow
+₹0 Cr
Institutional buyers
1 in / 1 out
High-impact filings
1 · tilt Neutral
Next corporate action
Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share
ex 2024-09-13
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | KIMSThis | — | — | 1 | — | — | — |
| 2 | ACMESOLAR | — | — | — | — | +3 | 6 |
| 3 | AADHARHFC | — | — | — | — | — | — |
| 4 | AARTIIND | — | — | — | — | — | — |
| 5 | ACE | — | — | — | — | — | — |
| 6 | ACUTAAS | — | — | — | — | +4 | 6 |
| 7 | ABLBL | — | — | — | — | — | — |
| 8 | AAVAS | −₹1.9 Cr | 2 | — | — | — | — |
| 9 | ABFRL | −₹142.6 Cr | 2 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2026-06-16FilingQualified institutions placement of equity shares of face value ₹ 2 each (the Equity Shares ) by KrishnGeneral
- 2026-06-16FilingAudited Standalone and Consolidated Financial Statements for the Financial Year ended 31st March 2026.Results
- 2026-06-13FilingKrishna Institute of Medical Sciences Limited has informed the Exchange regarding Outcome of Board Meeting helBoard Meeting
- 2026-06-11FilingDr. Bhaskara Rao Bollineni has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) read withShareholding Disclosure
- 2025-09-05BlockSELL · ₹18.1 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
- 2025-09-05BlockBUY · ₹18.1 CrGOLDMAN SACHS BANK EUROPE SE - ODI
- 2025-09-02BlockSELL · ₹36.5 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
- 2025-09-02BlockBUY · ₹36.5 CrGOLDMAN SACHS BANK EUROPE SE - ODI
- 2025-08-29BlockSELL · ₹18.6 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
- 2025-08-29BlockBUY · ₹18.6 CrGOLDMAN SACHS BANK EUROPE SE - ODI
- 2024-09-13ActionFace Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per ShareSplit
- 2024-08-28BlockBUY · ₹392 CrINFINITY PARTNERS
- 2024-08-28BlockSELL · ₹392 CrEMERALD INVESTMENTS LIMITED
- 2024-08-28BulkBUY · ₹392 CrINFINITY PARTNERS
- 2024-08-28BulkSELL · ₹392 CrEMERALD INVESTMENTS LIMITED
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2
- 7
- 2
- 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) read with Regulation 31(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF →
10 deals · 2024-08-28 → 2025-09-05
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2025-09-05 | GOLDMAN SACHS (SINGAPORE) PTE - ODI | HNI / other | SELL | ₹18.1 Cr |
| 2025-09-05 | GOLDMAN SACHS BANK EUROPE SE - ODI | HNI / other | BUY | ₹18.1 Cr |
| 2025-09-02 | GOLDMAN SACHS (SINGAPORE) PTE - ODI | HNI / other | SELL | ₹36.5 Cr |
| 2025-09-02 | GOLDMAN SACHS BANK EUROPE SE - ODI | HNI / other | BUY | ₹36.5 Cr |
| 2025-08-29 | GOLDMAN SACHS (SINGAPORE) PTE - ODI | HNI / other | SELL | ₹18.6 Cr |
| 2025-08-29 | GOLDMAN SACHS BANK EUROPE SE - ODI | HNI / other | BUY | ₹18.6 Cr |
| 2024-08-28 | INFINITY PARTNERS | Institution | BUY | ₹392 Cr |
| 2024-08-28 | EMERALD INVESTMENTS LIMITED | Institution | SELL | ₹392 Cr |
| 2024-08-28 | INFINITY PARTNERS | Institution | BUY | ₹392 Cr |
| 2024-08-28 | EMERALD INVESTMENTS LIMITED | Institution | SELL | ₹392 Cr |
10 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
Results & transcripts
News & chatter on KIMS
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.